ATHX - Athersys Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

22.94M

Cash

1.803M

Avg Qtr Burn

-8.224M

Short % of Float

4.77%

Insider Ownership

0.50%

Institutional Own.

11.31%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
MultiStem (MASTERS-2) Details Ischemic stroke	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MultiStem (MACoVIA) Details Acute respiratory distress syndrome, COVID-19	Phase 2/3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MultiStem (MATRICS-1) Details Trauma	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.